Nuvectis Pharma
NVCT
$6.15
Share price
-5.82%
Change (1 day)
-63.82%
Change (1 year)
Categories
Nuvectis Pharma (NVCT) - P/B ratio
P/B ratio as of May 2024 : 9.82
According to Nuvectis Pharma's latest financial reports the company has a price-to-book ratio of 9.82.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Nuvectis Pharma - P/B ratio (from 2022 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 11.8 | 53.35% |
| 2022-12-31 | 7.72 | |
| 2021-12-31 | N/A |